FDA records linked by MedtechLedger identify Pioneer Surgical Technology, Inc. dba EXALTA Group as an orthopedic device applicant filing under product code JDQ, the classification covering cerclage fixation devices. The applicant appears in two 510(k) clearances in the numbered sources: the Cerclage Cabling System, K262960, decided October 29, 2026, and the Cable-Ready® Cable Grip System, K261271, cleared July 16, 2026. Both are Class II filings. The K262960 record carries the Orthopedic advisory committee designation; the cited K261271 letter does not identify an advisory committee. The company name links the Pioneer Surgical Technology legal entity to the EXALTA Group brand, and EXALTA's own published material describes the group's formation and product scope. [1][4][7]
The Cerclage Cabling System clearance
K262960 covers a device named Cerclage Cabling System, filed by Pioneer Surgical Technology, Inc. dba EXALTA Group at 375 River Park Cir., Marquette, Michigan. The record shows a Traditional 510(k) received August 25, 2026, and decided October 29, 2026, with decision code SESE, meaning Substantially Equivalent. The device carries product code JDQ, regulation number 888.3010, classification name Cerclage, Fixation, device class 2, and the Orthopedic advisory committee designation. The filing included a summary rather than only a statement, and the third-party review flag is N. [1][7]
The same Marquette address appears on the earlier Cable-Ready® filing, where it is listed as the applicant address rather than a corporate headquarters. The contact named on the K262960 record is Michelle LeMieux. The record does not describe the system's components, materials, sizes or intended surgical use beyond the classification data. [1][4]
The Cable-Ready® Cable Grip System
The FDA clearance letter for K261271, dated July 16, 2026, names Pioneer Surgical Technology, Inc. as applicant and the Cable-Ready® Cable Grip System as the trade/device name. The submission was dated April 16, 2026, and received April 17, 2026. The letter lists regulation number 21 CFR 888.3010, regulation name Bone Fixation Cerclage, Class II, and product codes JDQ, KTT, HTN, HRS and HWC. The accompanying 510(k) summary, prepared April 16, 2026, gives the common name Cerclage, Fixation, and also references 888.3030 and 888.3040 classification names. [4]
The summary identifies the applicant contact as Sravyalahari Sripada, Senior Regulatory Specialist, with an EXALTA email address and the Marquette applicant address. The clearance letter is addressed to the same individual at the same address. These documents establish the filing's scope and classification; they do not report clinical results, comparative performance or post-market data. [4]
Applicant identity and the EXALTA Group brand
The FDA records distinguish the legal applicant from the brand. K262960 names Pioneer Surgical Technology, Inc. dba EXALTA Group, while K261271 names Pioneer Surgical Technology, Inc. with EXALTA contact details. EXALTA's own About page states that EXALTA Group was formed in 2025 through the merger of Intech, Resolve Surgical and Tyber Medical, and describes integrated OEM solutions across Spine, Extremities, Trauma, enabling technologies and Cardiothoracic. Those corporate statements are the publisher's account, not FDA findings. [1][2][4]
EXALTA's product catalog page for cabling describes cerclage and cable-based fixation solutions supporting cable and cerclage systems used in complex fixation and reconstruction procedures, and lists a single product entry, Crimps and Cable, under OEM-ready platforms. The page's market labels include Cardiothoracic, Extremities and Trauma. The catalog does not provide specifications, clearance numbers or availability details. [3]
What the filing record shows and does not show
In the collection retrieved for this profile, the linked portfolio contains one 510(k) record, K262960, with one SESE decision; that collection is an as-of snapshot of the filings retrieved, not a measure of the company's total portfolio, sales or safety performance. The explicitly smaller record sample likewise contains that single entry. A separate FDA query result for decisions between October 26 and December 31, 2026 reports 95 total results, and a query for October 15 to November 11, 2026 reports 192 total results; these are counts of those query results, not company totals. [1][5][6]
A third-party index page for K262960 repeats the applicant, product code, regulation, decision and review panel details and lists related records, including a 2020 sternal cable plate clearance attributed to Pioneer Surgical Technology, Inc. (dba RTI Surgical, Inc.). That related listing is outside the numbered FDA sources for this profile and is not treated here as a current company filing. No recall records appear in the retrieved collection. Manufacturing sites, customers, certifications and commercial availability are not established by these sources. [1][7]

